212 related articles for article (PubMed ID: 21930249)
1. Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.
Yao XH; Liu Y; Chen K; Gong W; Liu MY; Bian XW; Wang JM
Int Immunopharmacol; 2011 Dec; 11(12):1961-6. PubMed ID: 21930249
[TBL] [Abstract][Full Text] [Related]
2. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.
Ye XZ; Xu SL; Xin YH; Yu SC; Ping YF; Chen L; Xiao HL; Wang B; Yi L; Wang QL; Jiang XF; Yang L; Zhang P; Qian C; Cui YH; Zhang X; Bian XW
J Immunol; 2012 Jul; 189(1):444-53. PubMed ID: 22664874
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma.
Lu YB; Sun TJ; Chen YT; Cai ZY; Zhao JY; Miao F; Yang YN; Wang SX
Technol Cancer Res Treat; 2020; 19():1533033820948053. PubMed ID: 33089751
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells.
Yao X; Ping Y; Liu Y; Chen K; Yoshimura T; Liu M; Gong W; Chen C; Niu Q; Guo D; Zhang X; Wang JM; Bian X
PLoS One; 2013; 8(3):e57188. PubMed ID: 23536763
[TBL] [Abstract][Full Text] [Related]
6. The role of chemoattractant receptors in shaping the tumor microenvironment.
Zhou J; Xiang Y; Yoshimura T; Chen K; Gong W; Huang J; Zhou Y; Yao X; Bian X; Wang JM
Biomed Res Int; 2014; 2014():751392. PubMed ID: 25110692
[TBL] [Abstract][Full Text] [Related]
7. Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression.
Zhang Y; Wen YL; Ma JW; Ye JC; Wang X; Huang JX; Meng CY; Xu XZ; Wang SX; Zhong XY
Int J Oncol; 2017 Jan; 50(1):101-110. PubMed ID: 27909720
[TBL] [Abstract][Full Text] [Related]
8. Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target.
Chen S; Zhao H; Deng J; Liao P; Xu Z; Cheng Y
J Cell Biochem; 2013 Dec; 114(12):2795-808. PubMed ID: 23836528
[TBL] [Abstract][Full Text] [Related]
9. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
10. NEO212 Inhibits Migration and Invasion of Glioma Stem Cells.
Marín-Ramos NI; Thein TZ; Cho HY; Swenson SD; Wang W; Schönthal AH; Chen TC; Hofman FM
Mol Cancer Ther; 2018 Mar; 17(3):625-637. PubMed ID: 29440289
[TBL] [Abstract][Full Text] [Related]
11. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
12. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
13. An inhibitor of arachidonate 5-lipoxygenase, Nordy, induces differentiation and inhibits self-renewal of glioma stem-like cells.
Wang B; Yu SC; Jiang JY; Porter GW; Zhao LT; Wang Z; Tan H; Cui YH; Qian C; Ping YF; Bian XW
Stem Cell Rev Rep; 2011 Jun; 7(2):458-70. PubMed ID: 20809257
[TBL] [Abstract][Full Text] [Related]
14. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
15. Targeting glioma stem cells: a novel framework for brain tumors.
Binello E; Germano IM
Cancer Sci; 2011 Nov; 102(11):1958-66. PubMed ID: 21848914
[TBL] [Abstract][Full Text] [Related]
16. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells.
Yoon CH; Hyun KH; Kim RK; Lee H; Lim EJ; Chung HY; An S; Park MJ; Suh Y; Kim MJ; Lee SJ
FEBS Lett; 2011 Jul; 585(14):2331-8. PubMed ID: 21704033
[TBL] [Abstract][Full Text] [Related]
17. GSK‑3 inhibitor CHIR99021 enriches glioma stem‑like cells.
Yang Y; Wang QQ; Bozinov O; Xu RX; Sun YL; Wang SS
Oncol Rep; 2020 May; 43(5):1479-1490. PubMed ID: 32323804
[TBL] [Abstract][Full Text] [Related]
18. A synthetic dl-nordihydroguaiaretic acid (Nordy), inhibits angiogenesis, invasion and proliferation of glioma stem cells within a zebrafish xenotransplantation model.
Yang X; Cui W; Yu S; Xu C; Chen G; Gu A; Li T; Cui Y; Zhang X; Bian X
PLoS One; 2014; 9(1):e85759. PubMed ID: 24454929
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
20. Tumstatin attenuates the promotion effect of IL-17 secreted by Th17 cells on the stemness maintenance of glioma cells.
Yu W; Hu J; Le H; Lu Y; Xu W; Yu W; Shen W
Pathol Res Pract; 2021 Jul; 223():153463. PubMed ID: 33971545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
